These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 36480317)

  • 1. Hypertonic saline use in neurocritical care for treating cerebral edema: A review of optimal formulation, dosing, safety, administration and storage.
    Holden DN; Mucksavage JJ; Cokley JA; Kim KS; Tucker NL; Esordi MS; Cook AM
    Am J Health Syst Pharm; 2023 Mar; 80(6):331-342. PubMed ID: 36480317
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Guidelines for the Acute Treatment of Cerebral Edema in Neurocritical Care Patients.
    Cook AM; Morgan Jones G; Hawryluk GWJ; Mailloux P; McLaughlin D; Papangelou A; Samuel S; Tokumaru S; Venkatasubramanian C; Zacko C; Zimmermann LL; Hirsch K; Shutter L
    Neurocrit Care; 2020 Jun; 32(3):647-666. PubMed ID: 32227294
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety of peripheral 3% hypertonic saline bolus administration for neurologic emergency.
    Brown CS; Rabinstein AA; Zhao Y; Wieruszewski ED
    Am J Emerg Med; 2023 Jul; 69():83-86. PubMed ID: 37079938
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypertonic Saline for Increased Intracranial Pressure After Aneurysmal Subarachnoid Hemorrhage: A Systematic Review.
    Pasarikovski CR; Alotaibi NM; Al-Mufti F; Macdonald RL
    World Neurosurg; 2017 Sep; 105():1-6. PubMed ID: 28549643
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyperosmolar therapy in the treatment of severe head injury in children: mannitol and hypertonic saline.
    Knapp JM
    AACN Clin Issues; 2005; 16(2):199-211. PubMed ID: 15876888
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiac output changes after osmotic therapy in neurosurgical and neurocritical care patients: a systematic review of the clinical literature.
    Tsaousi G; Stazi E; Cinicola M; Bilotta F
    Br J Clin Pharmacol; 2018 Apr; 84(4):636-648. PubMed ID: 29247499
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypertonic saline versus other intracranial pressure-lowering agents for people with acute traumatic brain injury.
    Chen H; Song Z; Dennis JA
    Cochrane Database Syst Rev; 2019 Dec; 12(12):CD010904. PubMed ID: 31886900
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Osmotherapy for intracranial hypertension: mannitol versus hypertonic saline.
    Fink ME
    Continuum (Minneap Minn); 2012 Jun; 18(3):640-54. PubMed ID: 22810253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of 23.4% hypertonic saline for the management of elevated intracranial pressure in patients with severe traumatic brain injury: a pilot study.
    Kerwin AJ; Schinco MA; Tepas JJ; Renfro WH; Vitarbo EA; Muehlberger M
    J Trauma; 2009 Aug; 67(2):277-82. PubMed ID: 19667879
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of hypertonic saline on cerebrovascular reactivity and compensatory reserve in traumatic brain injury: an exploratory analysis.
    Froese L; Dian J; Batson C; Gomez A; Unger B; Zeiler FA
    Acta Neurochir (Wien); 2020 Nov; 162(11):2683-2693. PubMed ID: 32959342
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of hypertonic (3%) saline/acetate infusion in the treatment of cerebral edema: Effect on intracranial pressure and lateral displacement of the brain.
    Qureshi AI; Suarez JI; Bhardwaj A; Mirski M; Schnitzer MS; Hanley DF; Ulatowski JA
    Crit Care Med; 1998 Mar; 26(3):440-6. PubMed ID: 9504569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of hypertonic saline solutions in treatment of cerebral edema and intracranial hypertension.
    Qureshi AI; Suarez JI
    Crit Care Med; 2000 Sep; 28(9):3301-13. PubMed ID: 11008996
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypertonic saline reduces cumulative and daily intracranial pressure burdens after severe traumatic brain injury.
    Mangat HS; Chiu YL; Gerber LM; Alimi M; Ghajar J; Härtl R
    J Neurosurg; 2015 Jan; 122(1):202-10. PubMed ID: 25380107
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and efficacy of repeated doses of 14.6 or 23.4 % hypertonic saline for refractory intracranial hypertension.
    Lewandowski-Belfer JJ; Patel AV; Darracott RM; Jackson DA; Nordeen JD; Freeman WD
    Neurocrit Care; 2014 Jun; 20(3):436-42. PubMed ID: 24026522
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Standardized Volume Dosing Protocol of 23.4% Hypertonic Saline for Pediatric Critical Care: Initial Experience.
    Cummings BM; Fernandes ND; Parker LF; Murphy SA; Yager PH
    Ann Pharmacother; 2020 Sep; 54(9):866-871. PubMed ID: 32070111
    [No Abstract]   [Full Text] [Related]  

  • 16. Mannitol and Hypertonic Saline Reduce Swelling and Modulate Inflammatory Markers in a Rat Model of Intracerebral Hemorrhage.
    Schreibman DL; Hong CM; Keledjian K; Ivanova S; Tsymbalyuk S; Gerzanich V; Simard JM
    Neurocrit Care; 2018 Oct; 29(2):253-263. PubMed ID: 29700692
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of Intracranial Pressure Measurements Before and After Hypertonic Saline or Mannitol Treatment in Children With Severe Traumatic Brain Injury.
    Kochanek PM; Adelson PD; Rosario BL; Hutchison J; Miller Ferguson N; Ferrazzano P; O'Brien N; Beca J; Sarnaik A; LaRovere K; Bennett TD; Deep A; Gupta D; Willyerd FA; Gao S; Wisniewski SR; Bell MJ;
    JAMA Netw Open; 2022 Mar; 5(3):e220891. PubMed ID: 35267036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Osmotherapy: use among neurointensivists.
    Hays AN; Lazaridis C; Neyens R; Nicholas J; Gay S; Chalela JA
    Neurocrit Care; 2011 Apr; 14(2):222-8. PubMed ID: 21153930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Introducing hypertonic saline for cerebral edema: an academic center experience.
    Larive LL; Rhoney DH; Parker D; Coplin WM; Carhuapoma JR
    Neurocrit Care; 2004; 1(4):435-40. PubMed ID: 16174946
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety of Peripheral Line Administration of 3% Hypertonic Saline and Mannitol in the Emergency Department.
    Mesghali E; Fitter S; Bahjri K; Moussavi K
    J Emerg Med; 2019 Apr; 56(4):431-436. PubMed ID: 30745195
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.